Dr. Brandon J. Manderle, MD

Dr. Manderle practices at Bronson Methodist Hospital in Kalamazoo, Michigan, part of Bronson Healthcare Group.

Dr. Manderle's NPI, 1013576271, was assigned on June 11, 2019. Dr. Manderle graduated from Medical College of Wisconsin in 2018. Dr. Manderle holds Michigan license 4301505916.

Dr. Manderle's primary practice is Bronson Methodist Hospital, at 601 John Street, Kalamazoo, MI 49007 in Kalamazoo County. The practice phone is (269) 341-6000.

Dr. Manderle's primary practice is Bronson Methodist Hospital in Kalamazoo, Michigan, part of Bronson Healthcare Group. Dr. Manderle is also affiliated with Bronson Battle Creek Hospital. The medical group on file is Bronson Medical Group. Dmand AI also links Dr. Manderle to 1 more hospital, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Manderle practices, 5 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Manderle's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Manderle is licensed in Michigan.

CMS data shows 736 Medicare services from Dr. Manderle across 7 procedure codes in 2024, for 222 Medicare patients. Medicare paid $39,917 for them. Every service was in an office.

CMS counts 222 Medicare patients who saw Dr. Manderle in 2024. The largest group is 65 to 74, with 98 patients. 63% of them have high cholesterol, and 62% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Manderle's median patient age at 55, with 47% women.

In 2024, Dr. Manderle wrote 4,821 Medicare Part D claims for 527 patients. 86% of them were for generic drugs. CMS names the drug for 4,083 of them, across 97 drugs with 11 or more claims each, at $306,361 in total drug cost. In 2023, CMS named 1,978 claims across 64 drugs.

Dr. Manderle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Manderle as offering telehealth. CMS counts 12 procedures of removal of skin lesions by Dr. Manderle, more than 59% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Manderle, published from 2018 to 2021. 2018 was the busiest year, with 4. The most frequent topics are Arthroscopy. Dr. Manderle has published most often in Arthroscopy. Dr. Manderle's most frequent co-authors are Nikhil Verma, Alexander Beletsky, MD and Anirudh Krishna Gowd, MD.

CMS Open Payments shows 72 general payments to Dr. Manderle from 17 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $313.

Dr. Manderle graduated from Medical College of Wisconsin in 2018.